Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from Cann Group ( (AU:CAN) ) is now available.
Cann Group Limited has applied for quotation on the ASX of 15,300,442 new fully paid ordinary shares, with an issue date of 23 December 2025. The additional securities, arising from the exercise or conversion of existing options or other convertible instruments, will expand the company’s quoted share capital and may influence its capital structure, liquidity, and trading dynamics for existing and new shareholders.
The most recent analyst rating on (AU:CAN) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on Cann Group stock, see the AU:CAN Stock Forecast page.
More about Cann Group
Cann Group Limited is an Australian-listed company operating in the medical cannabis sector. It is involved in the cultivation and production of cannabis-derived products for medicinal and related markets, and its shares trade on the ASX under the code CAN.
Average Trading Volume: 5,190,075
Technical Sentiment Signal: Sell
Current Market Cap: A$14M
For a thorough assessment of CAN stock, go to TipRanks’ Stock Analysis page.